Canaan Inc. (CAN) stock
CANNasdaqFinance ServicesFiscal year ends December 31
$0.15−0.01 (-3.97%)
Close on Nov 13, 2026Market cap $110.94MP/E –Yield –
Canaan r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $63.15M, up 3.0% from the year before. The highest annual figure on record is $81.76M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.15M | +3.0% |
| FY2024 | Dec 31, 2024 | $61.32M | -5.4% |
| FY2023 | Dec 31, 2023 | $64.85M | -20.7% |
| FY2022 | Dec 31, 2022 | $81.76M | +56.7% |
| FY2021 | Dec 31, 2021 | $52.17M | +143.1% |
| FY2020 | Dec 31, 2020 | $21.46M | -11.6% |
| FY2019 | Dec 31, 2019 | $24.27M | – |
See a number that looks wrong?